Considerations of growth hormone treatment during the transition from adolescence to adulthood;Besonderheiten bei der Behandluncj mit Wachstumshormon während des Übergangs vom Jugendlichen zum Erwachsenen (Transition)

Deutsche Medizinische Wochenschrift

Volumn 134, Issue 21, 2009, Pages 1117-1120

  Ranke, M B ^a,c,d   Wallaschofski, H ^b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c Im Namen der KIGS Autorenschaft ^*

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENCE; ADULTHOOD; ALGORITHM; ENDOCRINOLOGY; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; REVIEW; SCORING SYSTEM; ADOLESCENT; ADULT; AGE; FEMALE; HUMAN; MALE; PITUITARY DWARFISM; QUALITY OF LIFE;

ADOLESCENT; ADULT; AGE FACTORS; ALGORITHMS; DWARFISM, PITUITARY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; QUALITY OF LIFE; YOUNG ADULT;

EID: 65549119221     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1222579     Document Type: Review

References (14)

1. Al-Shoumer KA, Gray R, Anyaoku V et al. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clin Endocrinol (Oxf) 1998; 48: 795-802
2. Baum HB, Biller BM, Finkelstein JS et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 1996; 125: 883-890
3. Bengtsson BA, Abs R, Bennmarker H et al. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board. J Clin Endocrinol Metab 1999; 84: 3929-3935
4. Casanueva FF, Castro Al, Micic D et al. New guidelines for the diagnosis of growth hormone deficiency in adults. Horm Res 2009; 71 Suppl 1: 112-115
5. Gasco V, Corneli G, Beccutl G et al. Retesting the childhood-onset GH- deficient patient. Eur J Endocrinol 2008; 159 Suppl 1: S45-52
6. Clayton PE, Cuneo RC, Juul A et al. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 2005; 152: 165-170
7. Corneli G, Di Somma C, Prodam F et al. Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. EurJ Endocrinol 2007; 157: 701-708
8. Gilchrist FJ, Murray RD, Shalet SM. The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults. Clin Endocrinol (Oxf) 2002; 57: 363-370
9. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on adult growth hormone deficiency. J Clin Endocrinol Metab 1998; 83: 379-81
10. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000; 85: 3990-3993
11. Ho KK on behalf of the 2007 GH Deficiency Consensus Workshop Participants . Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 2007; 157: 695-700
12. Hoffman AR, Kuntze JE, Baptista J et al. Growth hormone (GH) replacement therapy in adult-onset GH deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2004; 89: 2048-2056
13. Maison P, Griffin S, Nicoue-Beglah M et al. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a meta-analysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 2004; 89: 2192-2199
14. Svensson J, Sunnerhagen KS, Johannsson G. Five years of growth hormone replacement therapy in adults: age and gender related changes in isometric and isokinetic muscle strength. J Clin Endocrinol Metab 2003; 88: 2061-2069